ALDX - Aldeyra Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5213.68M
Enterprise Value 3-1.45M
Trailing P/E N/A
Forward P/E 1-4.41
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.36
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.04

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-35.63%
Return on Equity (ttm)-61.63%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -39.63M
Net Income Avi to Common (ttm)-38.89M
Diluted EPS (ttm)-1.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.6M
Total Cash Per Share (mrq)7.94
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.19
Book Value Per Share (mrq)3.30

Cash Flow Statement

Operating Cash Flow (ttm)-29.86M
Levered Free Cash Flow (ttm)-41.81M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.17
52-Week Change 37.83%
S&P500 52-Week Change 38.90%
52 Week High 316.70
52 Week Low 36.75
50-Day Moving Average 38.34
200-Day Moving Average 39.16

Share Statistics

Avg Vol (3 month) 3675.29k
Avg Vol (10 day) 3321.34k
Shares Outstanding 527.4M
Float 4.73M
% Held by Insiders 11.94%
% Held by Institutions 173.18%
Shares Short (Mar 29, 2019) 41.17M
Short Ratio (Mar 29, 2019) 40.82
Short % of Float (Mar 29, 2019) 48.09%
Short % of Shares Outstanding (Mar 29, 2019) 44.26%
Shares Short (prior month Feb 28, 2019) 4679.36k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A